On November 26, 2025, Actinium Pharmaceuticals, Inc. held its annual meeting, where directors Ajit S. Shetty and June S. Almenoff were re-elected for a term expiring in 2028, with a total of 15,494,573 shares present at the meeting. All proposals, including the appointment of CBIZ as accounting firm, were approved by stockholders.